SPEAR: CRISPR-mediated ultrasensitive, specific and rapid one-pot detection strategy for cancer-related SNPs
Theranostics · 18.02.2025 · 15 (8) · 3275-3288
DOI: 10.7150/thno.107488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, erschienen am 18.02.2025. Verfasst von Linlin Bai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Research and Innovation, Shanghai Pudong Hospital, Human Phenome Institute, State Key Laboratory of Genetic Engineering, School of…. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, CRISPR-Cas Systems, Neoplasms, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 33-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Rationale
The ultrasensitive and accurate detection of driver mutations is critical for early cancer screening and precision medicine.Current methods face challenges in balancing sensitivity, specificity, and speed, which limits their clinical utility.Therefore, a rapid, sensitive, and specific method is essential for detecting cancer-related SNPs.
Methods
This study introduces SPEAR (Specific Point mutation Evaluation via CRISPR-Cas Assisted Recognition), a novel methodology combining NEAR (Nicking Enzyme Amplification Reaction) isothermal amplification with SNP-specific recognition by Cas12b RNP in a one-pot configuration to detect cancer-related single nucleotide polymorphisms (SNPs).SPEAR leverages the power of NEAR isothermal amplification to efficiently amplify target DNA, followed by Cas12b RNP for SNP-specific recognition.This integrated approach ensures a rapid and precise mutation detection system in a single reaction. Results:The method was applied to blood samples for the detection of cancer-related mutations, with results obtained in approximately 30 min.The SPEAR enables detection of gene mutations at the single-molecule level and it can detect targets at a 0.1% ratio despite strong background interference.The method exhibits single-base resolution specificity, allowing for the detection of multiple SNPs in a single reaction.It outperforms first-generation sequencing (FGS) in both convenience and sensitivity, while remaining compatible with next-generation sequencing (NGS).
Conclusion
SPEAR offers a rapid, sensitive, and convenient approach to detect cancer-related SNPs, with significant potential for clinical applications, including real-time detection and molecular diagnostics in precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Medical Research and Innovation, Shanghai Pudong Hospital, Human Phenome Institute, State Key Laboratory of Genetic Engineering, School of Life Sciences, School of Pharmacy, Fudan University, Shanghai 200438,…
- Department of Gastroenterology, Shanghai Institute of Pancreatic Diseases, Changhai Hospital; National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai 200433, China.
- Department of Hematology, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China.
- College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China.
- Department of Hepatobiliary Pancreatic Surgery, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
- International Human Phenome Institutes, Shanghai 200433, China.
Zitieren
APA
Bai, L., Pang, Y., Wang, T., Wang, S., Guo, K., Xuan, T., Zhang, Z., Liu, D., Qian, F., Zheng, Y., Jin, G., & Wang, R. (2025). SPEAR: CRISPR-mediated ultrasensitive, specific and rapid one-pot detection strategy for cancer-related SNPs. Theranostics, 15(8), 3275-3288. https://doi.org/10.7150/thno.107488
Vancouver
Bai L, Pang Y, Wang T, Wang S, Guo K, Xuan T, et al. SPEAR: CRISPR-mediated ultrasensitive, specific and rapid one-pot detection strategy for cancer-related SNPs. Theranostics. 2025;15(8):3275-3288. doi:10.7150/thno.107488
BibTeX
@article{Bai2025,
author = {Bai, Linlin and Pang, Yanan and Wang, Ting and Wang, Shengzhou and Guo, Kaiming and Xuan, Tian and Zhang, Ziqin and Liu, Dianwei and Qian, Feng and Zheng, Yan and Jin, Gang and Wang, Rui},
title = {SPEAR: CRISPR-mediated ultrasensitive, specific and rapid one-pot detection strategy for cancer-related SNPs},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {8},
pages = {3275--3288},
doi = {10.7150/thno.107488}
}
EUVIMED